Mood and personality effects in healthy participants after chronic administration of sertraline

Journal of Affective Disorders

Volumn 134, Issue 1-3, 2011, Pages 377-385

  Simmons, Julian G ^a   Allen, Nicholas B ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Healthy adults; Mood; Personality; Selective serotonin reuptake inhibitors; Sertraline

Indexed keywords

PLACEBO; SERTRALINE;

ADULT; ARTICLE; ATTENTION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG EFFECT; FEMALE; GENOTYPE; GUILT; HUMAN; HUMAN EXPERIMENT; JOVIALITY; MALE; MOOD CHANGE; NEGATIVE AFFECT; PERSONALITY; POSITIVE AFFECT; PRIORITY JOURNAL; PSYCHOLOGICAL AND PSYCHIATRIC PHENOMENA; RANDOMIZED CONTROLLED TRIAL; SELF ASSURANCE; SELF REPORT; SERENITY;

AFFECT; ANTIDEPRESSIVE AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PERSONALITY; PERSONALITY DISORDERS; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; YOUNG ADULT;

EID: 80052507789     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.06.007     Document Type: Article

References (75)

1. M. aan het Rot, D.S. Moskowitz, G. Pinard, and S.N. Young Social behaviour and mood in everyday life: the effects of tryptophan in quarrelsome individuals J. Psychiatry Neurosci. 31 4 2006 253 262 (Pubitemid 44085831)
2. S. Almeida, D.C. Glahn, S.V. Argyropoulos, and S. Frangou Acute citalopram administration may disrupt contextual information processing in healthy males Eur. Psychiatry 25 2 2010 87 91
3. I.M. Anderson, C.M. Del-Ben, S. McKie, P. Richardson, S.R. Williams, and R. Elliott Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study Neuroreport 18 13 2007 1351 1355 (Pubitemid 47344320)
4. G. Bagdy, M. Graf, Z.E. Anheuer, E.A. Modos, and S. Kantor Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635 Int. J. Neuropsychopharmacol. 4 4 2001 399 408 (Pubitemid 33151684)
5. P. Banerjee, M. Mehta, and B. Kanjilal The 5-HT1A receptor: a signaling hub linked to emotional balance A. Chattopadhyay, Serotonin Receptors in Neurobiology 2007 CRC Press, Taylor & Francis Boca Raton, FL
6. L.C. Barr, G.R. Heninger, W. Goodman, D.S. Charney, and L.H. Price Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjects Biol. Psychiatry 41 9 1997 949 954 (Pubitemid 27213705)
7. A.T. Beck, and R.A. Steer Beck Depression Inventory Manual 1987 HBJ San Antonio
8. K.A. Berg, J.A. Harvey, U. Spampinato, and W.P. Clarke Physiological and therapeutic relevance of constitutive activity of 5-HT 2A and 5-HT 2C receptors for the treatment of depression Prog. Brain Res. 172 2008 287 305
9. N. Besnier, C. Casse-Perrot, E. Jouve, N. Nguyen, C. Lancon, and B. Falissard Effects of paroxetine on emotional functioning and treatment awareness: a 4-week randomized placebo-controlled study in healthy clinicians Psychopharmacology (Berl.) 207 4 2010 619 629
10. C.E. Beyer, and T.I. Cremers Do selective serotonin reuptake inhibitors acutely increase frontal cortex levels of serotonin? Eur. J. Pharmacol. 580 3 2008 350 354
11. Z. Bhagwagar, P.J. Cowen, G.M. Goodwin, and C.J. Harmer Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression Am. J. Psychiatry 161 1 2004 166 168 (Pubitemid 38419325)
12. K.L. Bigos, B.G. Pollock, H.J. Aizenstein, P.M. Fisher, R.R. Bies, and A.R. Hariri Acute 5-HT reuptake blockade potentiates human amygdala reactivity Neuropsychopharmacology 33 13 2008 3221 3225
13. L. Booij, W. Van der Does, C. Benkelfat, J.D. Bremner, P.J. Cowen, and M. Fava Predictors of mood response to acute tryptophan depletion. A reanalysis Neuropsychopharmacology 27 5 2002 852 861 (Pubitemid 35335901)
14. M.A. Brett, H.D. Dierdorf, B.D. Zussman, and P.E. Coates Determination of paroxetine in human plasma, using high-performance liquid chromatography with fluorescence detection J. Chromatogr. 419 1987 438 444 (Pubitemid 17141423)
15. M. Browning, C. Reid, P.J. Cowen, G.M. Goodwin, and C.J. Harmer A single dose of citalopram increases fear recognition in healthy subjects J. Psychopharmacol. 21 7 2007 684 690 (Pubitemid 47437913)
16. A. Caspi, A.R. Hariri, A. Holmes, R. Uher, and T.E. Moffitt Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits Am. J. Psychiatry 167 5 2010 509 527
17. K.P. Cosgrove, C.M. Mazure, and J.K. Staley Evolving knowledge of sex differences in brain structure, function, and chemistry Biol. Psychiatry 62 8 2007 847 855 (Pubitemid 47488220)
18. R.J. Davidson, P. Ekman, N.H. Frijda, H.H. Goldsmith, J. Kagan, and R. Lazarus How are emotions distinguished from moods, temperament, and other related affective constructs? P. Ekman, R.J. Davidson, The Nature of Emotion: Fundamental Questions 1994 Oxford University Press New York, NY 49 96
19. C.M. Del-Ben, J.F. Deakin, S. McKie, N.A. Delvai, S.R. Williams, and R. Elliott The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study Neuropsychopharmacology 30 9 2005 1724 1734 (Pubitemid 43090698)
20. L. Derogatis SCL-90-R Version: Manual I 1977 John Hopkins University Press Baltimore, MD
21. L. Du, D. Bakish, A.V. Ravindran, and P.D. Hrdina Does fluoxetine influence major depression by modifying five-factor personality traits? J. Affect. Disord. 71 1-3 2002 235 241
22. M. El Mansari, C. Sanchez, G. Chouvet, B. Renaud, and N. Haddjeri Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain Neuropsychopharmacology 30 7 2005 1269 1277 (Pubitemid 40848081)
23. D. Eyding, M. Lelgemann, U. Grouven, M. Harter, M. Kromp, and T. Kaiser Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials BMJ 341 2010 c4737
24. M.B. First, R.L. Spitzer, M. Gibbon, and J.B.W. Williams Structured Clinical Interview for Axis I DSM-IV Disorders 1994 New York State Psychiatric Institute New York
25. P.M. Furlan, M.J. Kallan, T.T. Have, I. Lucki, and I. Katz SSRIs do not cause affective blunting in healthy elderly volunteers Am. J. Geriatr. Psychiatry 12 3 2004 323 330 (Pubitemid 38569161)
26. C. Garcia-Leal, C. Del-Ben, F. Leal, F. Graeff, and F. Guimaraes Escitalopram prolonged fear induced by simulated public speaking and released hypothalamic-pituitary-adrenal axis activation J. Psychopharmacol. 24 5 2010 683 694
27. A.M. Gardier, I. Malagie, A.C. Trillat, C. Jacquot, and F. Artigas Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies Fundam. Clin. Pharmacol. 10 1 1996 16 27
28. J. Gelernter, H. Kranzler, and J.F. Cubells Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects Hum. Genet. 101 2 1997 243 246 (Pubitemid 28014742)
29. J. Gelernter, H. Kranzler, E.F. Coccaro, L.J. Siever, and A.S. New Serotonin transporter protein gene polymorphism and personality measures in African American and European American subjects Am. J. Psychiatry 155 10 1998 1332 1338 (Pubitemid 28471188)
30. J. Gelernter, J.F. Cubells, J.R. Kidd, A.J. Pakstis, and K.K. Kidd Population studies of polymorphisms of the serotonin transporter protein gene Am. J. Med. Genet. 88 1 1999 61 66 (Pubitemid 29075323)
31. A. Gerdelat-Mas, I. Loubinoux, D. Tombari, O. Rascol, F. Chollet, and M. Simonetta-Moreau Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects NeuroImage 27 2 2005 314 322 (Pubitemid 41074834)
32. C. Grillon, J. Levenson, and D.S. Pine A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study Neuropsychopharmacology 32 1 2007 225 231 (Pubitemid 44967801)
33. C.J. Harmer, Z. Bhagwagar, D.I. Perrett, B.A. Vollm, P.J. Cowen, and G.M. Goodwin Acute SSRI administration affects the processing of social cues in healthy volunteers Neuropsychopharmacology 28 1 2003 148 152
34. C.J. Harmer, N.C. Shelley, P.J. Cowen, and G.M. Goodwin Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition Am. J. Psychiatry 161 7 2004 1256 1263 (Pubitemid 38859176)
35. C.J. Harmer, C.E. Mackay, C.B. Reid, P.J. Cowen, and G.M. Goodwin Antidepressant drug treatment modifies the neural processing of nonconscious threat cues Biol. Psychiatry 59 9 2006 816 820
36. E.P. Hayden, D.N. Klein, H.I. Sheikh, T.M. Olino, L.R. Dougherty, and M.W. Dyson The serotonin transporter promoter polymorphism and childhood positive and negative emotionality Emotion 10 5 2010 696 702
37. K. Hinkelmann, L. Dragoi, J. Gompf, C. Muhtz, C. Demiralay, and A. Yassouridis Decreased recognition of negative affect after selective serotonin reuptake inhibition is dependent on genotype Psychiatry Res. 177 3 2010 354 357
38. J.R. Homberg, and K.P. Lesch Looking on the bright side of serotonin transporter gene variation Biol. Psychiatry 69 6 2010 513 519
39. P. Huezo-Diaz, R. Uher, R. Smith, M. Rietschel, N. Henigsberg, and A. Marusic Moderation of antidepressant response by the serotonin transporter gene Br. J. Psychiatry 195 1 2009 30 38
40. J.B. Jensen, D.S. Jessop, M.S. Harbuz, A. Mork, C. Sanchez, and J.D. Mikkelsen Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats J. Neuroendocrinol. 11 6 1999 465 471 (Pubitemid 29243770)
41. K. Karg, M. Burmeister, K. Shedden, and S. Sen The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation Arch. Gen. Psychiatry 68 5 2011 444 454
42. R. Keers, R. Uher, P. Huezo-Diaz, R. Smith, S. Jaffee, and M. Rietschel Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project Pharmacogenomics J. 11 2 2011 138 145
43. A.H. Kemp, M.A. Gray, R.B. Silberstein, S.M. Armstrong, and P.J. Nathan Augmentation of serotonin enhances pleasant and suppresses unpleasant cortical electrophysiological responses to visual emotional stimuli in humans NeuroImage 22 3 2004 1084 1096 (Pubitemid 38829197)
44. I. Kirsch, B.J. Deacon, T.B. Huedo-Medina, A. Scoboria, T.J. Moore, and B.T. Johnson Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration PLoS Med. 5 2 2008 e45
45. Y. Kitaichi, T. Inoue, S. Nakagawa, S. Boku, A. Kakuta, and T. Izumi Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats Eur. J. Pharmacol. 647 1-3 2010 90 96
46. B. Knutson, O.M. Wolkowitz, S.W. Cole, T. Chan, E.A. Moore, and R.C. Johnson Selective alteration of personality and social behavior by serotonergic intervention Am. J. Psychiatry 155 3 1998 373 379 (Pubitemid 28114895)
47. N. Kokras, C. Dalla, and Z. Papadopoulou-Daifoti Sex differences in pharmacokinetics of antidepressants Expert Opin. Drug Metab. Toxicol. 7 2 2011 213 226
48. C. McCabe, Z. Mishor, P.J. Cowen, and C.J. Harmer Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment Biol. Psychiatry 67 5 2010 439 445
49. C. Mombereau, T.L. Gur, J. Onksen, and J.A. Blendy Differential effects of acute and repeated citalopram in mouse models of anxiety and depression Int. J. Neuropsychopharmacol. 13 3 2010 321 334
50. S.E. Murphy, J. Yiend, K.J. Lester, P.J. Cowen, and C.J. Harmer Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers Int. J. Neuropsychopharmacol. 12 2 2009 169 179
51. B.A. Nic Dhonnchadha, N. Ripoll, F. Clenet, M. Hascoet, and M. Bourin Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test Psychopharmacology (Berl.) 179 2 2005 418 429 (Pubitemid 40569045)
52. R. Norbury, M.J. Taylor, S. Selvaraj, S.E. Murphy, C.J. Harmer, and P.J. Cowen Short-term antidepressant treatment modulates amygdala response to happy faces Psychopharmacology (Berl.) 206 2 2009 197 204
53. S.H. Preskorn Clinical Pharmacology of SSRI's First ed. 1996 Professional Communications, Inc. Caddo, OK
54. S.H. Preskorn Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism Clin. Pharmacokinet. 32 Suppl. 1 1997 1 21 (Pubitemid 27107715)
55. J.W. Richardson-Jones, C.P. Craige, B.P. Guiard, A. Stephen, K.L. Metzger, and H.F. Kung 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants Neuron 65 1 2010 40 52
56. W.J. Riedel, K. Eikmans, A. Heldens, and J.A. Schmitt Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment J. Psychopharmacol. 19 1 2005 12 20
57. O.J. Robinson, and B.J. Sahakian A double dissociation in the roles of serotonin and mood in healthy subjects Biol. Psychiatry 65 1 2009 89 92
58. E.J. Rose, E. Simonotto, E.P. Spencer, and K.P. Ebmeier The effects of escitalopram on working memory and brain activity in healthy adults during performance of the n-back task Psychopharmacology (Berl.) 185 3 2006 339 347
59. H.G. Ruhe, N.S. Mason, and A.H. Schene Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies Mol. Psychiatry 12 4 2007 331 359 (Pubitemid 46496835)
60. D. Seo, C.J. Patrick, and P.J. Kennealy Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disorders Aggress. Violent Behav. 13 5 2008 383 395
61. M. Serra, P. Salgado-Pineda, P. Delaveau, E. Fakra, C. Gasto, and O. Blin Effects of antidepressant drugs on emotion Clin. Neuropharmacol. 29 3 2006 170 185 (Pubitemid 44503900)
62. M. Siepmann, J. Grossmann, M. Muck-Weymann, and W. Kirch Effects of sertraline on autonomic and cognitive functions in healthy volunteers Psychopharmacology (Berl.) 168 3 2003 293 298 (Pubitemid 36920912)
63. Simmons, J.G., Allen, N.B., Judd, F.K., Norman, T.R., submitted for publication. The effects of fluoxetine on mood and emotional responsiveness.
64. J.J. Sramek, and N.R. Cutler The impact of gender on antidepressants Curr. Top. Behav. Neurosci. 2011 Epub ahead of print
65. T.Z. Tang, R.J. DeRubeis, S.D. Hollon, J. Amsterdam, R. Shelton, and B. Schalet Personality change during depression treatment: a placebo-controlled trial Arch. Gen. Psychiatry 66 12 2009 1322 1330
66. R. Tranter, H. Healy, D. Cattell, and D. Healy Functional effects of agents differentially selective to noradrenergic or serotonergic systems Psychol. Med. 32 3 2002 517 524 (Pubitemid 34308795)
67. W.S. Tse, and A.J. Bond Serotonergic involvement in the psychosocial dimension of personality J. Psychopharmacol. 15 3 2001 195 198 (Pubitemid 32808254)
68. W.S. Tse, and A.J. Bond Serotonergic intervention affects both social dominance and affiliative behaviour Psychopharmacology (Berl.) 161 3 2002 324 330 (Pubitemid 34591671)
69. Watson, D., Clark, L., 1994. The PANAS-X Manual. Unpublished: University of Iowa.
70. D. Watson, L. Clark, and A. Tellegen Development and validation of brief measures of positive and negative affect: The PANAS Scales J. Pers. Soc. Psychol. 54 1988 1063 1070
71. S.J. Wilson, J.E. Bailey, C. Alford, A. Weinstein, and D.J. Nutt Effects of 5 weeks of administration of fluoxetine and dothiepin in normal volunteers on sleep, daytime sedation, psychomotor performance and mood J. Psychopharmacol. 16 4 2002 321 331 (Pubitemid 35470576)
72. M. Wingen, J. Bothmer, S. Langer, and J.G. Ramaekers Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial J. Clin. Psychiatry 66 4 2005 436 443 (Pubitemid 40593571)
73. M. Yamauchi, T. Miyara, T. Matsushima, and T. Imanishi Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors Brain Res. 1067 1 2006 164 169 (Pubitemid 43133085)
74. S.N. Young, and M. Leyton The role of serotonin in human mood and social interaction. Insight from altered tryptophan levels Pharmacol. Biochem. Behav. 71 4 2002 857 865 (Pubitemid 34219235)
75. M. Zuckerman, D.M. Kuhlman, J. Joireman, P. Teta, and M. Kraft A comparison of three structural models for personality: the big three, the big five, and the alternative five J. Pers. Soc. Psychol. 65 4 1993 757 768